Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal.
about
Future pharmacological treatments for substance use disordersHindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functionsMitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafishInvolvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawalRole of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc)Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and WithdrawalSex differences between CRF1 receptor deficient mice following naloxone-precipitated morphine withdrawal in a conditioned place aversion paradigm: implication of HPA axisCP-154,526 Modifies CREB Phosphorylation and Thioredoxin-1 Expression in the Dentate Gyrus following Morphine-Induced Conditioned Place PreferenceMorphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons functionThe dark side of emotion: the addiction perspectiveIncreased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawalNicotine stimulates secretion of corticosterone via both CRH and AVP receptors.Effect of berberine on depression- and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in rats.Addiction is a Reward Deficit and Stress Surfeit Disorder.Addiction as a stress surfeit disorder.Acupuncture Stimulation Attenuates Impaired Emotional-Like Behaviors and Activation of the Noradrenergic System during Protracted Abstinence following Chronic Morphine Exposure in Rats.Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawalOpioids inhibit visceral afferent activation of catecholamine neurons in the solitary tract nucleus.Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal.Preventive effect of central administration of venlafaxine on morphine physical dependence, nociception, and blood cortisol level in rat.CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.Induction of FosB/DeltaFosB in the brain stress system-related structures during morphine dependence and withdrawal.Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal.Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal.
P2860
Q22242633-24F9297A-35D3-492C-B497-E5A12B24D212Q28296208-C361778D-4EE3-4030-AB0F-82F6027F22CEQ28478509-4FE6F189-20D2-467E-8639-F2EA1813F4F8Q28480798-FB774504-DC4E-485E-A72E-3DF3720816D7Q28484325-26EF929E-8C72-47A3-9D57-DBFF19B4AC07Q28534147-BFBFA08A-FCA8-4BBC-B69B-481E7FD19849Q28545272-2D09D067-4D71-4624-90E1-F9154AB59574Q28547523-2B3A74F9-C64F-486E-818C-1B5C698DB1BFQ28583554-B9507448-033F-4DBA-910C-09B7E2982CE5Q35235813-E81CC2CD-04E8-430B-AC72-7804E0406398Q35518471-56CF78BB-1DAC-449E-8FC5-F5300C0660B2Q35812772-36D5CE58-1787-4EFA-BA93-A7A7F90E9F51Q36479098-A5DA585A-6DFB-491E-97A6-18D222445261Q37061135-730D59B1-7419-4661-90EE-84FADC08D22FQ37315976-D532C564-6566-4F3A-A236-A19A87380AC9Q37550977-E61A1032-E322-404C-8EE4-265598BC5556Q37671294-09E8072D-8A43-4399-8201-7B5165B65CE8Q37721475-9F87FE03-66B3-4725-9264-FBA45135DBE8Q41924903-C655F143-CCB6-4B92-B7A3-A34E6E626F12Q42133806-1A37E46F-B990-4FEF-A3EE-A4BCD5897A03Q42618279-2AD003F7-238B-42D8-8DED-043EB30D1BFFQ43076002-D3D21C82-FC28-433F-B2D9-DB9E9EF98E63Q43632330-DAAF19A4-ACE6-4354-B6C8-2FA43E428205Q52146549-0E333A21-E675-4BD4-870A-E7818D837758
P2860
Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effects of corticotropin-relea ...... ponses to morphine withdrawal.
@ast
Effects of corticotropin-relea ...... ponses to morphine withdrawal.
@en
Effects of corticotropin-relea ...... ponses to morphine withdrawal.
@nl
type
label
Effects of corticotropin-relea ...... ponses to morphine withdrawal.
@ast
Effects of corticotropin-relea ...... ponses to morphine withdrawal.
@en
Effects of corticotropin-relea ...... ponses to morphine withdrawal.
@nl
prefLabel
Effects of corticotropin-relea ...... ponses to morphine withdrawal.
@ast
Effects of corticotropin-relea ...... ponses to morphine withdrawal.
@en
Effects of corticotropin-relea ...... ponses to morphine withdrawal.
@nl
P2093
P356
P1476
Effects of corticotropin-relea ...... ponses to morphine withdrawal.
@en
P2093
Cristina Núñez
Javier Navarro-Zaragoza
M Luisa Laorden
M Victoria Milanés
P304
P356
10.1124/MOL.109.062463
P577
2010-02-16T00:00:00Z